Wedbush lowered shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from an outperform rating to a neutral rating in a research note released on Wednesday, MarketBeat reports. They currently have $12.00 price objective on the stock, down from their previous price objective of $38.00. Wedbush also issued estimates for Zentalis Pharmaceuticals’ Q4 2023 earnings at […]
SVB Leerink Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) to Market Perform etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Zentalis Pharmaceuticals (NASDAQ:ZNTL) PT Lowered to $38.00 at Morgan Stanley themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) shares dropped 4.1% on Monday . The company traded as low as $17.22 and last traded at $17.22. Approximately 162,213 shares traded hands during mid-day trading, a decline of 77% from the average daily volume of 709,252 shares. The stock had previously closed at $17.95. Analysts Set […]
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) traded down 3.2% on Monday . The stock traded as low as $18.21 and last traded at $18.34. 146,579 shares were traded during trading, a decline of 79% from the average session volume of 706,325 shares. The stock had previously closed at $18.94. Wall Street […]